Novo Nordisk
Lonni Glanville is a seasoned executive with extensive experience at Novo Nordisk, where since April 2006, Lonni has held multiple roles as Corporate Vice President, overseeing quality assurance and compliance in various sectors including Aseptic Manufacturing, Injectable Finished Products, Biopharm Finished Products, and Purification Plants related to Diabetes API. With a strong focus on production and quality control, Lonni has successfully managed large teams across global production sites in China, France, Brazil, the US, and Denmark. Previously, from January 1997 to April 2005, Lonni served as Senior Manager and Professional in Quality Control Laboratories, emphasizing microbiological testing to ensure the quality and release of API and finished products. Lonni's academic background includes a Bachelor's degree in Chemistry from the Technical University of Denmark, obtained from 1990 to 1994.
This person is not in any teams
This person is not in any offices